| 51 |
31819048 | Vitamin D promotes the cisplatin sensitivity of oral squamous cell carcinoma by inhibiting LCN2-modulated NF-κB pathway activation through RPS3. | 2019 Dec 9 |
1 |
| 52 |
31895687 | Ubenimex induces autophagy inhibition and EMT suppression to overcome cisplatin resistance in GC cells by perturbing the CD13/EMP3/PI3K/AKT/NF-κB axis. | 2019 Dec 31 |
1 |
| 53 |
29386467 | Alkaloids from Stephania venosa as Chemo-Sensitizers in SKOV3 Ovarian Cancer Cells via Akt/NF-κB Signaling. | 2018 |
5 |
| 54 |
29393335 | Schizandrin B inhibits the cis‑DDP‑induced apoptosis of HK‑2 cells by activating ERK/NF‑κB signaling to regulate the expression of survivin. | 2018 Apr |
2 |
| 55 |
29524521 | Decrease in paracellular permeability and chemosensitivity to doxorubicin by claudin-1 in spheroid culture models of human lung adenocarcinoma A549 cells. | 2018 May |
1 |
| 56 |
29567488 | Blockade of nuclear factor-κB (NF-κB) pathway inhibits growth and induces apoptosis in chemoresistant ovarian carcinoma cells. | 2018 Jun |
2 |
| 57 |
29572052 | Long noncoding RNA DANCR mediates cisplatin resistance in glioma cells via activating AXL/PI3K/Akt/NF-κB signaling pathway. | 2018 Sep |
3 |
| 58 |
29743526 | Pretreatment of Huaiqihuang extractum protects against cisplatin-induced nephrotoxicity. | 2018 May 9 |
1 |
| 59 |
29950928 | ETS1 is associated with cisplatin resistance through IKKα/NF-κB pathway in cell line MDA-MB-231. | 2018 |
1 |
| 60 |
30104883 | Combination chemotherapy with Zyflamend reduced the acquired resistance of bladder cancer cells to cisplatin through inhibiting NFκB signaling pathway. | 2018 |
2 |
| 61 |
30274235 | Chemoresistance in H-Ferritin Silenced Cells: The Role of NF-κB. | 2018 Sep 28 |
1 |
| 62 |
30464531 | TRIM32 overexpression improves chemoresistance through regulation of mitochondrial function in non-small-cell lung cancers. | 2018 |
1 |
| 63 |
27754745 | GFRA1 promotes cisplatin-induced chemoresistance in osteosarcoma by inducing autophagy. | 2017 Jan 2 |
2 |
| 64 |
27995416 | Synergistic action of cisplatin and echistatin in MDA-MB-231 breast cancer cells. | 2017 Mar |
1 |
| 65 |
28119452 | MicroRNA-375 Is Induced in Cisplatin Nephrotoxicity to Repress Hepatocyte Nuclear Factor 1-β. | 2017 Mar 17 |
3 |
| 66 |
28123844 | Targeting NF-κB/AP-2β signaling to enhance antitumor activity of cisplatin by melatonin in hepatocellular carcinoma cells. | 2017 |
3 |
| 67 |
28182789 | Puerarin attenuates cisplatin-induced rat nephrotoxicity: The involvement of TLR4/NF-κB signaling pathway. | 2017 |
2 |
| 68 |
28255357 | STAT3/NF-κB-Regulated Lentiviral TK/GCV Suicide Gene Therapy for Cisplatin-Resistant Triple-Negative Breast Cancer. | 2017 |
2 |
| 69 |
28400607 | PID1 increases chemotherapy-induced apoptosis in medulloblastoma and glioblastoma cells in a manner that involves NFκB. | 2017 Apr 11 |
2 |
| 70 |
28415048 | Baicalein increases cisplatin sensitivity of A549 lung adenocarcinoma cells via PI3K/Akt/NF-κB pathway. | 2017 Jun |
6 |
| 71 |
28498503 | p62/SQSTM1 as an oncotarget mediates cisplatin resistance through activating RIP1-NF-κB pathway in human ovarian cancer cells. | 2017 Jul |
2 |
| 72 |
28518145 | Cytoplasmic RAP1 mediates cisplatin resistance of non-small cell lung cancer. | 2017 May 18 |
4 |
| 73 |
28978336 | The oncogenic Golgi phosphoprotein 3 like overexpression is associated with cisplatin resistance in ovarian carcinoma and activating the NF-κB signaling pathway. | 2017 Oct 4 |
1 |
| 74 |
29228621 | Synergism of ursolic acid and cisplatin promotes apoptosis and enhances growth inhibition of cervical cancer cells via suppressing NF-κB p65. | 2017 Nov 14 |
1 |
| 75 |
26476534 | TAB3 overexpression promotes cell proliferation in non-small cell lung cancer and mediates chemoresistance to CDDP in A549 cells via the NF-κB pathway. | 2016 Mar |
1 |
| 76 |
26673543 | The peroxisome proliferator-activated receptor γ agonist pioglitazone prevents NF-κB activation in cisplatin nephrotoxicity through the reduction of p65 acetylation via the AMPK-SIRT1/p300 pathway. | 2016 Feb 1 |
7 |
| 77 |
26704389 | Inhibition of nuclear factor κB transcription activity drives a synergistic effect of cisplatin and oridonin on HepG2 human hepatocellular carcinoma cells. | 2016 Apr |
3 |
| 78 |
26722370 | Triple-Layered pH-Responsive Micelleplexes Loaded with siRNA and Cisplatin Prodrug for NF-Kappa B Targeted Treatment of Metastatic Breast Cancer. | 2016 |
3 |
| 79 |
26782341 | 1,25-Dihydroxyvitamin D3 alleviates salivary adenoid cystic carcinoma progression by suppressing GPX1 expression through the NF-κB pathway. | 2016 Mar |
1 |
| 80 |
27322140 | Androgen receptor activity modulates responses to cisplatin treatment in bladder cancer. | 2016 Aug 2 |
6 |
| 81 |
27470347 | Interferon β improves the efficacy of low dose cisplatin by inhibiting NF-κB/p-Akt signaling on HeLa cells. | 2016 Aug |
2 |
| 82 |
25348361 | DNA-PKcs deficiency sensitizes the human hepatoma HepG2 cells to cisplatin and 5-fluorouracil through suppression of the PI3K/Akt/NF-κB pathway. | 2015 Jan |
4 |
| 83 |
25462204 | Brown algae phlorotannins enhance the tumoricidal effect of cisplatin and ameliorate cisplatin nephrotoxicity. | 2015 Feb |
1 |
| 84 |
25499851 | MnSOD overexpression confers cisplatin resistance in lung adenocarcinoma via the NF-κB/Snail/Bcl-2 pathway. | 2015 Feb |
4 |
| 85 |
25681684 | Differential activation of NF-κB signaling is associated with platinum and taxane resistance in MyD88 deficient epithelial ovarian cancer cells. | 2015 Apr |
7 |
| 86 |
25799148 | Modulation of NF-κB/miR-21/PTEN pathway sensitizes non-small cell lung cancer to cisplatin. | 2015 |
5 |
| 87 |
26055133 | Protective effect of Artemisia asiatica (Pamp.) Nakai ex Kitam ethanol extract against cisplatin-induced apoptosis of human HaCaT keratinocytes: Involvement of NF-kappa B- and Bcl-2-controlled mitochondrial signaling. | 2015 Jun 1 |
1 |
| 88 |
26079730 | Knockdown of Eag1 Expression by RNA Interference Increases Chemosensitivity to Cisplatin in Ovarian Cancer Cells. | 2015 Dec |
1 |
| 89 |
26118633 | Saikosaponin-D reduces cisplatin-induced nephrotoxicity by repressing ROS-mediated activation of MAPK and NF-κB signalling pathways. | 2015 Sep |
2 |
| 90 |
26300057 | Silencing of PKC-α, TRPC1 or NF-κB expression attenuates cisplatin-induced ICAM-1 expression and endothelial dysfunction. | 2015 Nov 1 |
1 |
| 91 |
26429874 | URGCP/URG4 promotes apoptotic resistance in bladder cancer cells by activating NF-κB signaling. | 2015 Oct 13 |
2 |
| 92 |
26491668 | Synergistic Inhibitory Effects of Cetuximab and Cisplatin on Human Colon Cancer Cell Growth via Inhibition of the ERK-Dependent EGF Receptor Signaling Pathway. | 2015 |
2 |
| 93 |
26498527 | Dunnione ameliorates cisplatin-induced small intestinal damage by modulating NAD(+) metabolism. | 2015 Nov 27 |
2 |
| 94 |
26503358 | Caveolin-1 mediates chemoresistance in cisplatin-resistant ovarian cancer cells by targeting apoptosis through the Notch-1/Akt/NF-κB pathway. | 2015 Dec |
2 |
| 95 |
26617729 | Activation of unfolded protein response protects osteosarcoma cells from cisplatin-induced apoptosis through NF-κB pathway. | 2015 |
4 |
| 96 |
26693062 | IKK phosphorylation of NF-κB at serine 536 contributes to acquired cisplatin resistance in head and neck squamous cell cancer. | 2015 |
7 |
| 97 |
24300974 | Gambogic acid synergistically potentiates cisplatin-induced apoptosis in non-small-cell lung cancer through suppressing NF-κB and MAPK/HO-1 signalling. | 2014 Jan 21 |
4 |
| 98 |
24418212 | Different affinity of nuclear factor-kappa B proteins to DNA modified by antitumor cisplatin and its clinically ineffective trans isomer. | 2014 Mar |
5 |
| 99 |
24490130 | NFκB mediates cisplatin resistance through histone modifications in head and neck squamous cell carcinoma (HNSCC). | 2014 |
3 |
| 100 |
24581167 | [The effect and mechanism of vinorelbine on cisplatin resistance of human lung cancer cell line A549/DDP]. | 2014 Feb |
1 |